Skip to main content
Erschienen in: World Journal of Urology 4/2018

19.02.2018 | Topic Paper

Robotic surgery in public hospitals of Latin-America: a castle of sand?

verfasst von: Fernando P. Secin, Rafael Coelho, Juan I. Monzó Gardiner, Jose Gadú Campos Salcedo, Roberto Puente, Levin Martínez, Diana Finkelstein, Rair Valero, Antonio León, Daniel Angeloni, José Rozanec, Milton Berger, Leandro Totti Cavazzola, Eliney Ferreira Faria, Roberto Días Machado, Felipe Lott, Franz Campos, Jorge G. Morales Montor, Carlos Sánchez Moreno, Hugo Dávila Barrios

Erschienen in: World Journal of Urology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

There is no information about the evolution of robotic programs in public hospitals of Latin-America.

Objective

To describe the current status and functioning of robotic programs in Latin-American public hospitals since their beginning to date.

Methods

We conducted a survey among leading urologists working at public hospitals of Latin-America who had acquired the Da Vinci laparoscopic-assisted robotic system. Questions included: date the program started, its utilization by other services, number and kind of surgeries, surgery paying system, surgery related deaths, occurrence and reasons of robotic program interruptions and its use for training purposes. Medians and 25–75 centiles (IQR) were estimated.

Results

Since 2009, there are ten public hospitals of four Latin-American countries that acquired the Da Vinci robotic system. The median number of months robotic programs has been functioning without considering transitory interruption: 43 (IQR 35, 55). Median number of urologic and total surgeries performed: 140 (IQR 94, 168) and 336 (IQR 292, 621), respectively. The corresponding median number of urologic and total surgeries performed per month: 3 (IQR 2, 5) and 8 (IQR 5, 11). Median number of total surgeries performed per year per institution was 94 (IQR 68,123). The median proportion of urologic cases was 40% (IQR 31, 48), ranging from 24 to 66%. Five of ten institutions had their urology programs transitory or definitively closed due to the high burden costs.

Conclusion

Adoption and development of robotic surgery in some public hospitals of Latin-America have been hindered by high costs.
Literatur
1.
Zurück zum Zitat Patel VR, Sivaraman A, Coelho RF, Chauhan S, Palmer KJ, Orvieto MA, Camacho I, Coughlin G, Rocco B (2011) Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59:702–707CrossRefPubMed Patel VR, Sivaraman A, Coelho RF, Chauhan S, Palmer KJ, Orvieto MA, Camacho I, Coughlin G, Rocco B (2011) Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59:702–707CrossRefPubMed
2.
Zurück zum Zitat Altman DG, Schulz KF, Moher D, Egger M, Davidoff F et al (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663–694CrossRefPubMed Altman DG, Schulz KF, Moher D, Egger M, Davidoff F et al (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663–694CrossRefPubMed
3.
Zurück zum Zitat Menon M, Shrivastava A, Tewari A, Sarle R, Hemal A, Peabody JO, Vallancien G (2002) Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol 168:945–949CrossRefPubMed Menon M, Shrivastava A, Tewari A, Sarle R, Hemal A, Peabody JO, Vallancien G (2002) Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol 168:945–949CrossRefPubMed
4.
Zurück zum Zitat Hemal AK, Menon M (2002) Laparoscopy, robot, telesurgery and urology: future perspective. J Postgrad Med 48:39–41PubMed Hemal AK, Menon M (2002) Laparoscopy, robot, telesurgery and urology: future perspective. J Postgrad Med 48:39–41PubMed
5.
Zurück zum Zitat Porpiglia F, Morra I, Lucci Chiarissi M, Manfredi M, Mele F, Grande S, Ragni F, Poggio M, Fiori C (2013) Randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy. Eur Urol 63(4):606–614CrossRefPubMed Porpiglia F, Morra I, Lucci Chiarissi M, Manfredi M, Mele F, Grande S, Ragni F, Poggio M, Fiori C (2013) Randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy. Eur Urol 63(4):606–614CrossRefPubMed
6.
Zurück zum Zitat Gardiner RA, Yaxley J, Coughlin G, Dunglison N, Occhipinti S, Younie S, Carter R, Williams S, Medcraft RJ, Bennett N, Lavin MF, Chambers SK (2012) A randomised trial of robotic and open prostatectomy in men with localised prostate cancer. BMC Cancer 25(12):189CrossRef Gardiner RA, Yaxley J, Coughlin G, Dunglison N, Occhipinti S, Younie S, Carter R, Williams S, Medcraft RJ, Bennett N, Lavin MF, Chambers SK (2012) A randomised trial of robotic and open prostatectomy in men with localised prostate cancer. BMC Cancer 25(12):189CrossRef
7.
Zurück zum Zitat Yaxley JW, Coughlin GD, Chambers SK et al (2016) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 388:1057–1066CrossRefPubMed Yaxley JW, Coughlin GD, Chambers SK et al (2016) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 388:1057–1066CrossRefPubMed
8.
Zurück zum Zitat Schroeck FR, Jacobs BL, Bhayani SB, Nguyen PL, Penson D, Hu J (2017) Cost of new technologies in prostate cancer treatment: systematic review of costs and cost effectiveness of robotic assisted laparoscopic prostatectomy, intensity-modulated radiotherapy, and proton beam therapy. Eur Urol 72(5):712–735CrossRefPubMed Schroeck FR, Jacobs BL, Bhayani SB, Nguyen PL, Penson D, Hu J (2017) Cost of new technologies in prostate cancer treatment: systematic review of costs and cost effectiveness of robotic assisted laparoscopic prostatectomy, intensity-modulated radiotherapy, and proton beam therapy. Eur Urol 72(5):712–735CrossRefPubMed
10.
Zurück zum Zitat Gil-Villa SA, Campos-Salcedob JG, Zapata-Villalba MA et al (2016) Prostatectomía radical laparoscópica asistida por robot, un año de experiencia en el Hospital Central Militar, reporte de los primeros 55 casos. Rev Mex Urol 76(2):87–93 Gil-Villa SA, Campos-Salcedob JG, Zapata-Villalba MA et al (2016) Prostatectomía radical laparoscópica asistida por robot, un año de experiencia en el Hospital Central Militar, reporte de los primeros 55 casos. Rev Mex Urol 76(2):87–93
11.
Zurück zum Zitat Barbash GI, Glied SA (2010) New technology and health care costs–the case of robot-assisted surgery. N Engl J Med 363(8):701–704CrossRefPubMed Barbash GI, Glied SA (2010) New technology and health care costs–the case of robot-assisted surgery. N Engl J Med 363(8):701–704CrossRefPubMed
12.
Zurück zum Zitat Ratchanon S, Apiwattanasawee P, Prasopsanti K (2015) A Cost-Utility Analysis of Laparoscopic Radical Prostatectomy and Robotic-Assisted Laparoscopic Radical Prostatectomy in Men with Localized Prostate Cancer in Thailand. J Med Assoc Thai 98(Suppl. 1):S14–S20PubMed Ratchanon S, Apiwattanasawee P, Prasopsanti K (2015) A Cost-Utility Analysis of Laparoscopic Radical Prostatectomy and Robotic-Assisted Laparoscopic Radical Prostatectomy in Men with Localized Prostate Cancer in Thailand. J Med Assoc Thai 98(Suppl. 1):S14–S20PubMed
13.
Zurück zum Zitat Ho C, Tsakonas E, Tran K et al (2011) Robot-assisted surgery compared with open surgery and laparoscopic surgery: clinical effectiveness and economic analyses. CADTH Technology Report, No. 137. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health Ho C, Tsakonas E, Tran K et al (2011) Robot-assisted surgery compared with open surgery and laparoscopic surgery: clinical effectiveness and economic analyses. CADTH Technology Report, No. 137. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health
14.
Zurück zum Zitat Marino P, Houvenaeghel G, Narducci F et al (2015) Cost-effectiveness of conventional vs robotic-assisted laparoscopy in gynecologic oncologic indications. Int J Gynecol Cancer 25(6):1102–1108PubMed Marino P, Houvenaeghel G, Narducci F et al (2015) Cost-effectiveness of conventional vs robotic-assisted laparoscopy in gynecologic oncologic indications. Int J Gynecol Cancer 25(6):1102–1108PubMed
15.
Zurück zum Zitat Desille-Gbaguidi Hl, Hebert T, Paternotte-Villemagne J, Gaborit C, Rush E, Body G (2013) Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer. Eur J Obstet Gynecol Reprod Biol 171(2):348–352CrossRefPubMed Desille-Gbaguidi Hl, Hebert T, Paternotte-Villemagne J, Gaborit C, Rush E, Body G (2013) Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer. Eur J Obstet Gynecol Reprod Biol 171(2):348–352CrossRefPubMed
16.
Zurück zum Zitat Basto M, Sathianathen N, Te Marvelde L et al (2016) Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system. BJU Int 117:930–939CrossRefPubMed Basto M, Sathianathen N, Te Marvelde L et al (2016) Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system. BJU Int 117:930–939CrossRefPubMed
17.
Zurück zum Zitat O'Donnell O (2007) Access to health care in developing countries: breaking down demand side barriers. Cad Saude Publica 23(12):2820–2834CrossRefPubMed O'Donnell O (2007) Access to health care in developing countries: breaking down demand side barriers. Cad Saude Publica 23(12):2820–2834CrossRefPubMed
18.
Zurück zum Zitat Louie-Johnsun MW, Handmer MM, Calopedos RJ et al (2016) The Australian laparoscopic non robotic radical prostatectomy experience—analysis of 2943 cases (USANZ supplement). BJU Int 118(Suppl 3):43–48CrossRefPubMed Louie-Johnsun MW, Handmer MM, Calopedos RJ et al (2016) The Australian laparoscopic non robotic radical prostatectomy experience—analysis of 2943 cases (USANZ supplement). BJU Int 118(Suppl 3):43–48CrossRefPubMed
20.
Zurück zum Zitat Bochner BH, Sjoberg DD, Laudone VP (2014) A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 371:389–390CrossRefPubMed Bochner BH, Sjoberg DD, Laudone VP (2014) A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 371:389–390CrossRefPubMed
Metadaten
Titel
Robotic surgery in public hospitals of Latin-America: a castle of sand?
verfasst von
Fernando P. Secin
Rafael Coelho
Juan I. Monzó Gardiner
Jose Gadú Campos Salcedo
Roberto Puente
Levin Martínez
Diana Finkelstein
Rair Valero
Antonio León
Daniel Angeloni
José Rozanec
Milton Berger
Leandro Totti Cavazzola
Eliney Ferreira Faria
Roberto Días Machado
Felipe Lott
Franz Campos
Jorge G. Morales Montor
Carlos Sánchez Moreno
Hugo Dávila Barrios
Publikationsdatum
19.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2227-5

Weitere Artikel der Ausgabe 4/2018

World Journal of Urology 4/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.